Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.576
+0.028 (5.11%)
At close: Dec 20, 2024, 4:00 PM
0.579
+0.003 (0.59%)
After-hours: Dec 20, 2024, 7:23 PM EST
Athira Pharma Market Cap
Athira Pharma has a market cap or net worth of $22.27 million as of December 20, 2024. Its market cap has decreased by -68.70% in one year.
Market Cap
22.27M
Enterprise Value
-45.27M
1-Year Change
-68.70%
Ranking
Category
Stock Price
$0.58
Market Cap Chart
Since the IPO on September 18, 2020, Athira Pharma's market cap has decreased from $489.85M to $22.27M, a decrease of -95.45%. That is a compound annual growth rate of -51.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 22.27M | -75.91% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | 1.11B | 127.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeurAxis | 21.79M |
| Kairos Pharma | 21.71M |
| Pulmatrix | 21.59M |
| Cocrystal Pharma | 21.36M |
| Equillium | 21.26M |
| Lisata Therapeutics | 21.16M |
| NanoViricides | 20.80M |
| VSee Health | 20.68M |